Researchers Identify Novel Approach To Create Red Blood Cells, Platelets In Vitro
6/04/2013
Finding could reduce need for blood donations, speed up research on therapies to treat diseases A study led by Boston University School of Medicine has identified a novel approach to create an unlimited number of human red blood cells and platelets in vitro...
Inostics' Blood-Based Mutation Testing Receives CLIA Certification
6/04/2013
Inostics, a molecular diagnostics company that provides blood-based mutation testing, received CLIA (Clinical Laboratory Improvement Amendments) licensure for its clinical laboratory located in Baltimore, MD. This marks a critical milestone for the clinical adoption of this non-invasive molecular approach for the analysis of tumor biomarkers...
Promising New Treatment For Advanced Melanoma
6/04/2013
Researchers from UCLA's Jonsson Comprehensive Cancer Center report that a new drug in preliminary tests has shown promising results with very manageable side effects for treating patients with melanoma, the deadliest form of skin cancer. The results were presented at the 2013 meeting of the American Society of Clinical Oncology today in Chicago by Dr...
Cancer Pain Eased By Therapy That Heats And Destroys Bone Tumors
6/04/2013
Patients with cancer that has spread to their bones are often treated with radiation therapy to reduce pain. But if that treatment doesn't work, or can't be used again, a second, effective option now exists...
A Wide Variety Of Advanced Cancers Harbor Abnormalities In HER2 Gene
6/04/2013
The HER2 growth-factor gene is known to be over-active in breast and gastro-esophageal cancers. But now, irregularities in the genes 's expression - among them mutations, amplifications, substitutions, and translocations - have been found in 14 different advanced solid tumors...
Splicing Process Hijacked By Oncogene Mutation To Promote Growth And Survival
6/04/2013
An international team of researchers - led by principal investigator Paul S...
Progression Of Glioblastoma May Be Accelerated By Cytomegalovirus
6/04/2013
A virus that infects most Americans but that usually remains dormant in the body might speed the progression of an aggressive form of brain cancer when particular genes are shut off in tumor cells, new research shows. The animal study by researchers at the Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J...
MarginProbe System Makes Breast Cancer Surgery More Precise
6/04/2013
Any breast cancer surgeon who regularly performs lumpectomies confronts the question "Did I get it all?" Thirty to 60 percent of the time in the U.S., the answer is "no," requiring the patient to undergo a second surgery to remove the remaining tumor...
In Metastatic Uveal Melanoma, New Drug Improves Progression-Free Survival, Shrinks Tumors
6/04/2013
The experimental drug selumetinib is the first targeted therapy to demonstrate significant clinical benefit for patients with metastatic uveal melanoma, according to new Memorial Sloan-Kettering Cancer Center research presented at the 49th annual meeting of the American Society of Clinical Oncology (ASCO). The findings are potentially practice-changing for a historically "untreatable disease...
Research teams led by Massachusetts General Hospital (MGH) Cancer Center investigators are publishing two important studies regarding use of the targeted cancer drug crizotinib for treatment of advanced lung cancer driven by specific genetic mutations...